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Purpose/Objective: Aim of our work was the implementation of FMEA 
(Failure mode and effects analysis). We used the FMEA in the analysis 
of the process: 'Radiotherapy Treatment', to identify possible errors, 
consequent effects of them, and to apply improvement suggestions of 
risk reduction. 
Materials and Methods: At the beginning of 2010, at our Radiotherapy 
Department, a risk management dedicated working group was set up. 
'Radiotherapy treatment' was the process chosen for the analysis, i.e. 
the patient’s course since the first radiotherapy session till the 
treatment’s end. All the different failure modes, requiring 
containment actions, were identified and ranked, based on severity 
(S), occurrence probability (OP), and probability that this particular 
failure would go undetected (D). Each event was rated to assign a risk 
probability numbers (RPN), in terms of severity according to Technical 
Commission of Risk Management scale, and in terms of probability of 
occurrence and failure according to the JCHAO modified scale, each 
one on a scale of 1 to 5. The RPN for each failure mode has been 
identified on a tabulated scores multiplying together the three value 
of S, OP and D parameters. Before we analyzed a total of 19 different 
failure modes, and after we reported the RPN for each event in a 
prioritization matrix divided into risk classes (low, intermediate and 
high risk). Finally for each failure modes we studied its containment 
action to be applied to RPN to decrease the risk class. 
Results: In our work the seven failure modes, classified in the high 
risk prioritization matrix, were considered for interventional 
solutions. The activities were: 1) lack of notes for electron treatments 
for head and neck cancer, 2) wrong phase sequence planning after 
treatment stop, 3) exchange of patients at the waiting room call, 4) 
lack of EPID control, 5) missing control request for the EPID by the 
technician, 6) collision between the Linac gantry and the patient, 7) 
lack of planning for the visits during therapy. The containment actions 
for each failure mode were respectively: 1) reductions in the usage of 
phases with electrons, 2) planning of one phase at a time, 3) delivery 
of identification badge, sporting name, surname and treatment sheet 
number, to show before each session, 4) annotation by the radiation 
oncologist of all verifications to repeat, 5) double check by the 
technicians that the EPID control was requested, 6) test of all fields 
during the first session, with added explanation notes, 7) planning on 
an electronic calendar of the visits during the therapy. With the 
application of the containment action we obtained a significant 
reduction of the risk factor score in all the failure modes considered.  
Conclusions: All identified containment actions were introduced by 
December 2011. At the end of 2012 their efficacy will be measured, 
by re-evaluation of all indexes based on the occurrences during the 
year. 
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Purpose/Objective: The median age in India in 2012 is 26.5 (male 
25.9 and female 27.2) where as the life expectancy has grown to 
67.14 (male 66.08 and female 68.33). Life expectancy was 31 in 1947, 
the year India got Independence. With increased life expectancy 
cancer incidence is on the rise. Healthcare delivery in India has 
witnessed a sea change in the new millennium. Oncology, especially 
radiation oncology has made quantum jumps, by way of acquisition of 
high tech and expensive equipment. A country with a population 
touching 1.25 billion and now among the top 4 economies of the world 
India has the potency for many more high end technologies including 
Particle and Proton therapy facilities. A study of the growth of 
radiotherapy technology in India in the new millennium is done. 
Materials and Methods: India with its colonial history has traditionally 
been a low-tech and manpower intensive healthcare provider. The 
new millennium however has brought the new era of reforms and 
economic development. Recent infusion of technology across the 
country and paradoxical abilities of making such technologies 
economically viable in all major disciplines of medicine, be it Cardiac 
Care or Robotic Surgeries, is noteworthy. In radiotherapy there is 
several fold addition of equipment with capabilities like 3D CRT, 
IMRT, IGRT, Stereotactic Body Radiotherapy, Robotic Radiosurgery and 
Helical Tomotherapy in several centers in various parts of India. The 
data and trends of growth of each of these technologies in India is 
studied.  
Results: India had its first linear accelerator in 1982 and had its first 
linear accelerator based dedicated stereotactic radiosurgery in 1996, 
The total number of linear accelerators remained in single digit till 
2000.The first IMRT was delivered in 2001, but the lag between 
technology adoption narrowed significantly in the later part of the 
decade. Linear Accelerators grew from 22 in early 2002 to 237 by 
March 2012, an impressive growth of more than 1000% in a decade. 
Cobalt units have reduced from 258 in 2003 to 237 in 2012 and many 
more are being decommissioned. HDR brachy therapy units have 
grown from 50 in 2003 to 200 in 2012, a fourfold increase. The same is 
true in diagnostic facilities like the PET-CT scanners and 3T MRI and 
related equipment. With highly acclaimed competencies in core 
scientific communities in the field of Nuclear Physics and Nuclear 
Engineering in place, it is very likely that India will have its own 
particle therapy facility in this decade itself. 
Conclusions: The acquisition of high-end equipment in radiotherapy in 
India is significant both quantitatively and qualitatively. India is 
known for its scientific achievements in atomic energy, space 
sciences, satellite communication, missile technology and information 
technology (IT). The current trend certainly gives India an edge in 
healthcare too.The gap of accessibility and affordability however is 
there and is beyond the purview of the current study. The 
transformation of Indian health care is real and radiotherapy in India 
is all set to achieve new heights. 
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Purpose/Objective: The radiodermatitis is the most frequent reaction 
during the accomplishment of external beem radiotherapy. Clinicaly 
radiodermatitis is manifested with appearance of erythema, dry and 
moist desquamation. Its prevention and treatment are necessary for 
the aim of accomplishing the planned therapeutic dose. 
Materials and Methods: In the Clinic of Radiotherapy within the 
National Hospital of Oncology for the period March – July 2012, 
prevention and treatment was carried out of acute radiodermatitis 
with Water Jel R1 and R2 on 30 patients. In 27 of the cases, the 
preparations were applied after the appearance of the radiodermatitis 
1st degree as per CTCAE v. 4. This usually occurs after realization 
oftotal dose of 30-36Gy, and in 3 of the patients for prevention from 
radiodermatitis from the beginning to the end of the radiotherapy. 
The patients from the first group suffer from carcinoma in the head 
and neck area and are undergoing definitive radiotherapy or chemo-
radiotherapy treatment, the three patients from the second group - 
carcinoma in the mammary gland and undergoing postoperative 
radiotherapy. 
Results: Affecting the symptoms of the radiodermatitis, such as pain, 
dryness and erythema has been observed immediatly after the first 
application of the two products Water Jel R1 and R2. 
In two of the patients with carcinoma in head and neck, after the 
application of the preparations, the realization of surdosage for the 
field of the primary tumor up to 70Gy became possible, without 
discontinuing the radiotherapy after 60 Gy. In patients for whom 
preventive treatment has been performed with Water Jel R1 andR2 
appearance of radiodermatitis 1st degree was not observed at all, but 
only slight pigmentation at the end of the radiotherapy. 
Conclusions: The application of the two preparations Water Jel R1 
and R2 is: easy and convenient for the patients, as the subjective 
complaints are being influenced (such as pain, dryness and erythema) 
as well as the comfort during the radiotherapy is improved. The 
improvement of the tolerance towards the treatment is present and at 
the same time the discontinuation due to appearance of 
radiodermatitis of 2nd and 3rd degree is avoided, whereas no side 
effects are observed. In the clinical practice these preparations can 
